News & Analysis as of

Research and Development Investors

Goodwin

One Big Beautiful Bill Act - Tax Highlights related to Research and Experimental Expenditures, Qualified Small Business Stock and...

Goodwin on

On July 4, 2025, the One Big Beautiful Bill Act (OBBB) was signed into law. The OBBB extends various expiring tax provisions from the Tax Cuts and Jobs Act (TCJA) and introduces a variety of other substantial tax law changes....more

Fenwick & West LLP

DARPA Extends Submission Deadline for RFI

Fenwick & West LLP on

Important opportunity for investors in the defense innovation and dual-use technology sectors!  The Defense Advanced Research Projects Agency (DARPA) has issued a Request for Information (RFI) that could be a perfect fit...more

Fenwick & West LLP

10 Must-Know Tech Facts About LA's Silicon Beach

Fenwick & West LLP on

Beyond the glitz of Hollywood, Los Angeles has quickly emerged as a formidable player in the tech scene. A triad of eager startups, established industry leaders, and forward-thinking investors fosters a tech ecosystem that...more

Foley & Lardner LLP

The Next Frontier for Artificial Intelligence in 2025

Foley & Lardner LLP on

Everyone is closely watching developments in the artificial intelligence (AI) space in terms of advancements, regulations, and investment. As we go to print on this post, SoftBank’s Vision Fund has just announced its...more

McDermott Will & Emery

Key Takeaways | Pharma and MedTech Services Market Overview With McKinsey & Company

McDermott Will & Emery on

During this session, McDermott Partner Kristian Werling and Jeff Smith, a senior partner at McKinsey & Company, shared insights across the pharma and MedTech services industries, including key trends and opportunities shaping...more

McDermott Will & Emery

Pharma and MedTech Services Investment Summit 2024

McDermott Will & Emery on

The inaugural Pharma and MedTech Services Investment Summit brought together C-suite executives, senior private equity professionals, investment bankers and other industry leaders for a deep dive into the investment...more

McDermott Will & Emery

[Event] Pharma and MedTech Services Investment Summit 2024 - May 2nd, San Francisco, CA

McDermott Will & Emery on

YOUR SOURCE FOR SUCCESS IN PHARMA AND DEVICE SERVICES INVESTING - Join C-suite executives, senior private equity professionals, investment bankers and other industry leaders for a deep dive into the investment...more

Maynard Nexsen

Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 181: South Carolina’s Life Sciences Economy with Ashely...

Maynard Nexsen on

Recorded at SCbio’s 2024 annual conference, hosts Heather and Matthew welcome Ashely Teasdel, Deputy Secretary for the South Carolina Department of Commerce. Ashely is a key player in South Carolina’s economic development and...more

A&O Shearman

Draft EU Foreign Investment Screening Regulation sets out more comprehensive screening regime

A&O Shearman on

On 24 January 2024, the European Commission (EC) published its proposed reform of foreign investment screening in the EU. The proposal introduces more comprehensive rules for the review of foreign investments and strengthens...more

McDermott Will & Emery

Transaction Trends in Life Sciences

In November, we were delighted to once again host our annual European Health & Life Sciences Symposium in Paris. The event attracted a large number of healthcare professionals, investors and dealmakers to the Shangri-La Hotel...more

Morgan Lewis - Health Law Scan

Get Ready, Set, and Go to the JPM Healthcare Conference

As Prescribed and Health Law Scan subscribers know that the end of the holidays means the annual J.P. Morgan (JPM) Healthcare Conference is only days away. To make the most of the 2024 conference and conference-adjacent...more

Latham & Watkins LLP

Life Sciences Product Development Needs More Creative Fundraising

Latham & Watkins LLP on

The life sciences industry depended historically on public offerings for fundraising to support costs of developing therapeutic pharmaceutical and biologic products. The average cost of discovering and developing these...more

Davis Wright Tremaine LLP

Project W: Uncovering a Promising Sector in Climate Tech

The food and ag sectors are tied to nearly a quarter of all global greenhouse gas emissions. However, those sectors receive disproportionately less climate tech venture funding. Beatriz Franco and Maya Benami of Vita Vera...more

Pillsbury Winthrop Shaw Pittman LLP

Exploring R&D Opportunities under the CHIPS Act

The CHIPS R&D Office is advancing innovation and creating opportunities across industry. $11 billion has been appropriated to the CHIPS Research and Development Office to advance research and development of semiconductor...more

DarrowEverett LLP

Florida Business Climate Great for Pickleball, But Risks Are in Play

DarrowEverett LLP on

When discussing the ever-evolving landscape of Florida’s commercial real estate (CRE) market, one trend has begun to stand out — the rise of pickleball. This sport, once a leisurely pastime, has turned into a compelling...more

Maynard Nexsen

Approaching Deadline for the 2022 Benchmark Survey of Foreign Direct Investment in the US: What You Need to Know

Maynard Nexsen on

Foreign direct investment (FDI) plays a crucial role in the global economy, and the United States has long been an attractive destination for international investors. To accurately gauge the impact and trends of FDI, the US...more

Goodwin

Current Issues for Qualified Small Business Stock - How New R&E Expensing Rules Could Hurt Your QSBS Status, and Why Cash...

Goodwin on

An early-stage company can offer prospective investors an attractive investment opportunity, particularly if the company’s stock will qualify as “qualified small business stock” (QSBS) for US federal income tax purposes. This...more

Morrison & Foerster LLP

A New Listing Regime for Specialist Technology Companies Has Arrived

On March 24, 2023, the Stock Exchange of Hong Kong Limited (the “Exchange”) issued the long-awaited consultation conclusions (the “Consultation Conclusions”) on the listing regime for Specialist Technology Companies on the...more

Ballard Spahr LLP

Key Takeaways From the 2023 JP Morgan Healthcare Conference: A Buyers’ M&A Market and More

Ballard Spahr LLP on

Summary - The 41st Annual JP Morgan Healthcare Conference in rainy San Francisco earlier this month was relatively low-key compared to pre-pandemic versions of the health care investment symposium, which returned this year...more

Perkins Coie

Sweeping Appropriations Act of 2023 Makes Unprecedented Investments in AI

Perkins Coie on

Perhaps missed over the holidays, the mammoth $1.7 trillion Consolidated Appropriations Act of 2023 (the Act) was signed into law by President Biden on December 29, 2022. It includes record levels of funding for a wide range...more

Allen Matkins

Life Sciences Real Estate Update -1.06.23 #1

Allen Matkins on

California’s lab and biotech industries provide 435,693 jobs that generate $376 billion in total economic output, according to a new report from Biocom California, an association representing life sciences companies and...more

International Lawyers Network

It`s Not Only Patents: Planning and Implementing to Protect Innovation

For investors in innovation, it is a priority to count on legal mechanisms to secure some level of exclusivity in the exploitation of their innovations, to seek a return on their investment. The first legal alternative...more

Allen Matkins

Life Sciences Real Estate Update - October 2022

Allen Matkins on

Newmark: U.S. life sciences investment dips but main hubs dodge headwinds - Commercial Observer – September 29 - Overall investment in the national life sciences market is shrinking, but the drop in venture capital funding...more

Allen Matkins

Life Sciences Real Estate Update - May 2022

Allen Matkins on

Developers look to office-to-lab conversions to meet life sciences demand Bullet GlobeSt.com – April 29 As demand for lab space among life sciences companies continues to skyrocket, developers are increasingly looking to a...more

Cozen O'Connor

Ceres Guidance for Engaging on Climate Risk Governance and Voting on Directors

Cozen O'Connor on

Ceres, a nonprofit organization focused on solving climate and sustainability challenges through coordinated action by capital market leaders, recently issued its 2022 Guidance for Engaging on Climate Risk Governance and...more

38 Results
 / 
View per page
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide